Table 1

Prognostic scores used to predict post operative outcomes in patients with chronic liver disease

Child-Turcotte-Pugh (CTP)Score123
Albumin (g/L)>3528–35<28
Clotting (INR)<1.71.7–2.2>2.2
AscitesNoneDiuretic responsiveDiuretic resistant
EncephalopathyNoneGrade 1 or 2Grade 3 or 4
Total score5–67–910–15
Model for End-Stage Liver Disease (MELD)Creatinine (μmol/L)
Bilirubin (μmol/L)
Clotting (INR)
Dialysis at least twice in past week
Formula = (0.957 x ln (Serum Cr) + 0.378 x ln (serum Bilirubin) + 1.120 x ln (INR)+0.643) x 10 (if haemodialysis, value for creatinine is automatically set to 4.0)
ASAASA I—Normal healthy patient
ASA II—Patient with mild systemic disease
ASA III—Patient severe systemic disease that is not a constant threat to life
ASA IV—Patient with severe systemic disease that is a constant threat to life
ASA V—Moribund patient not expected to survive with or without surgery
ADOPT-LCAge (years)
Charlson Comorbidity index
CTP Class
Anaesthesia duration
Mayo Postoperative Mortality Risk Score (
ASA Score
Bilirubin (mg/dL)
Creatinine (mg/dL)
Aetiology of cirrhosis
VOCAL-Penn ( (Years)BMI >30
Albumin (g/L)NAFLD aetiology
Bilirubin (μmol/L)ASA score
Platelet count (×109/L)Emergency surgery
Surgery type
  • ADOPT-LC, Adequate Operative Treatment for Liver Cirrhosis; ASA, American Society of Anesthesiologists; BMI, body mass index; INR, international normalised ratio; NAFLD, non-alcoholic fatty liver disease.